Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.30
Bid: 1.20
Ask: 1.40
Change: -0.20 (-13.33%)
Spread: 0.20 (16.667%)
Open: 1.25
High: 1.30
Low: 1.05
Prev. Close: 1.50
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Physiomics wins first contract from Numab Therapeutics

Tue, 11th May 2021 17:50

Physiomics PLC - oncology consultant based in Oxford - Awarded its first contract by Zurich-based biopharmaceutical company Numab Therapeutics, which is focused on developing biotherapeutics for chronic inflammation and cancer.

"We are delighted that Numab has selected Physiomics to support them with one of their new programs and look forward to working with their highly talented team," notes Chief Executive Officer Jim Millen.

Current stock price: 5.91 pence

Year-to-date change: down 20%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
10 Nov 2020 15:43

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
16 Oct 2020 16:37

IN BRIEF: Physiomics Pens New Merck KGaA, Bicycle Therapeutics Deals

IN BRIEF: Physiomics Pens New Merck KGaA, Bicycle Therapeutics Deals

Read more
16 Oct 2020 09:30

Physiomics awarded further contracts with Bicycle Therapeutics and Merck

(Sharecast News) - Oncology consultancy Physiomics has been awarded further contracts of an undisclosed value for projects with existing clients Bicycle Therapeutics and Merck.

Read more
30 Sep 2020 15:43

IN BRIEF: Physiomics Annual Revenue Grows And Loss Narrows

IN BRIEF: Physiomics Annual Revenue Grows And Loss Narrows

Read more
4 Aug 2020 19:16

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

UK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic

Read more
31 Jul 2020 12:08

Physiomics wins contract with Japan-based Astellas Pharma

(Sharecast News) - Oncology consultancy Physiomics announced on Friday that it has been awarded a contract by a new client, Japan-based global pharmaceutical company Astellas Pharma.

Read more
22 Jul 2020 20:43

IN BRIEF: Physiomics Has No Explanation For Share Price Surge

IN BRIEF: Physiomics Has No Explanation For Share Price Surge

Read more
27 May 2020 17:13

Physiomics Raises New Funds To "Further Develop Its Business"

Physiomics Raises New Funds To "Further Develop Its Business"

Read more
27 May 2020 10:30

Physiomics raises £829,000 to fund further development

(Sharecast News) - Oncology consultancy Physiomics has raised roughly £829,000 through a share issue to finance further development.

Read more
6 Apr 2020 17:20

Physiomics Secures Additional Contract With Bicycle Therapeutics

Physiomics Secures Additional Contract With Bicycle Therapeutics

Read more
19 Mar 2020 12:44

Physiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak

Physiomics Believes Strong Pipeline Can Withstand Covid-19 Oubtreak

Read more
10 Mar 2020 11:39

Physiomics receives 'Connect' funding award from NIHR

(Sharecast News) - Oncology consulting company Physiomics has received a 'Connect' award from the National Institute for Health Research's (NIHR) 'Invention for Innovation' (i4i) programme, for the continued development of its tool for use in the personalised treatment of cancer.

Read more
5 Mar 2020 13:57

Physiomics Secures Contract Extension With Existing Client Merck

Physiomics Secures Contract Extension With Existing Client Merck

Read more
3 Mar 2020 11:11

Physiomics First Half Revenue Rises But No Grants Means Widened Loss

Physiomics First Half Revenue Rises But No Grants Means Widened Loss

Read more
3 Mar 2020 10:19

Physiomics H1 revenues on the rise

(Sharecast News) - Oncology consultancy Physiomics said on Tuesday that interim losses had widened despite posting an improvement in revenues.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.